New light therapy aims to halt cornea disease and save sight
Disease control
Recruiting now
This study tests a device that uses riboflavin (vitamin B2) drops and UV light to stiffen the cornea, the clear front part of the eye. It is for people with keratoconus or similar conditions that cause the cornea to bulge and blur vision. The goal is to see if the treatment safel…
Phase: PHASE2 • Sponsor: Goodman Eye Center • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC